Healthcare provider profile · identity verified

Kenny Dewayne Hefner, MD

Internal Medicine · N WILKESBORO, NC · NPI 1699747329

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	361	104
Atorvastatin Calcium	Atorvastatin Calcium	232	67
Rosuvastatin Calcium	Rosuvastatin Calcium	214	66
Lisinopril	Lisinopril	210	58
Metoprolol Succinate	Metoprolol Succinate	199	55
Pantoprazole Sodium	Pantoprazole Sodium	199	58
Omeprazole	Omeprazole	192	51
Levothyroxine Sodium	Levothyroxine Sodium	190	60
Furosemide	Furosemide	164	52
Metformin Hcl	Metformin Hcl	157	44
Simvastatin	Simvastatin	153	39
Hydrochlorothiazide	Hydrochlorothiazide	140	35
Glimepiride	Glimepiride	130	34
Sertraline Hcl	Sertraline Hcl	122	35
Gabapentin	Gabapentin	116	40
Losartan Potassium	Losartan Potassium	113	30
Fluticasone Propionate	Fluticasone Propionate	102	47
Tamsulosin Hcl	Tamsulosin Hcl	101	31
Metoprolol Tartrate	Metoprolol Tartrate	97	25
Famotidine	Famotidine	96	27
Trazodone Hcl	Trazodone Hcl	93	30
Pravastatin Sodium	Pravastatin Sodium	92	23
Citalopram Hbr	Citalopram Hydrobromide	90	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	11
Potassium Chloride	Potassium Chloride	81	23
Buspirone Hcl	Buspirone Hcl	77	16
Clonazepam	Clonazepam	75	17
Bupropion Hcl Sr	Bupropion Hcl	67	19
Metformin Hcl Er	Metformin Hcl	61	19
Ozempic	Semaglutide	59	suppressed
Meloxicam	Meloxicam	58	19
Montelukast Sodium	Montelukast Sodium	58	22
Albuterol Sulfate Hfa	Albuterol Sulfate	57	25
Fluoxetine Hcl	Fluoxetine Hcl	57	17
Jardiance	Empagliflozin	56	15
Eliquis	Apixaban	55	12
Allopurinol	Allopurinol	54	13
Atenolol	Atenolol	53	13
Doxycycline Hyclate	Doxycycline Hyclate	50	38
Duloxetine Hcl	Duloxetine Hcl	49	12
Fluconazole	Fluconazole	47	26
Meclizine Hcl	Meclizine Hcl	47	14
Colchicine	Colchicine	46	11
Alprazolam	Alprazolam	45	suppressed
Carvedilol	Carvedilol	43	11
Nortriptyline Hcl	Nortriptyline Hcl	43	12
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	11
Mirtazapine	Mirtazapine	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	14
Verapamil Er	Verapamil Hcl	36	suppressed
Glipizide	Glipizide	35	suppressed
Topiramate	Topiramate	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Lorazepam	Lorazepam	34	suppressed
Donepezil Hcl	Donepezil Hcl	32	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Mometasone Furoate	Mometasone Furoate	30	11
Spironolactone	Spironolactone	30	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	22
Finasteride	Finasteride	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	11
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Cephalexin	Cephalexin	26	16
Januvia	Sitagliptin Phosphate	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Cefuroxime	Cefuroxime Axetil	25	21
Ondansetron Odt	Ondansetron	25	11
Tramadol Hcl	Tramadol Hcl	25	suppressed
Prednisone	Prednisone	24	17
Tizanidine Hcl	Tizanidine Hcl	24	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Nystatin	Nystatin	19	14
Temazepam	Temazepam	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	11
Xarelto	Rivaroxaban	17	suppressed
Amoxicillin	Amoxicillin	16	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Nitroglycerin	Nitroglycerin	15	12
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error